ask="N/A"
ask_size="N/A"
average_daily_volume="54430"
bid="14.00"
bid_size="1000"
book_value="6.38"
change="+0.17"
change_from_200_day_moving_average="-1.06"
change_from_50_day_moving_average="-0.44"
change_from_52_week_high="-5.24"
change_From_52_week_low="2.44"
change_in_percent="+1.11%"
close="15.50"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.59"
ebitda="-58.67M"
eps_estimate_current_year="-3.87"
eps_estimate_next_quarter="-0.96"
eps_estimate_next_year="-3.58"
ex_dividend_date="N/A"
float_shares="9110000"
high="15.64"
high_52_weeks="20.74"
last_trade_date="3/15/2017"
last_trade_price="15.50"
last_trade_size="5723"
last_trade_time="4:00pm"
low="15.10"
low_52_weeks="13.06"
market_capitalization="336.74M"
moving_average_200_day="16.56"
moving_average_50_day="15.94"
name="Audentes Therapeutics
Inc."
notes="N/A"
one_year_target_price="N/A"
open="15.19"
pe_ratio="N/A"
peg_ratio="-0.63"
percent_change_from_200_day_moving_average="-6.41%"
percent_change_from_50_day_moving_average="-2.73%"
percent_change_from_52_week_high="-25.27%"
percent_change_from_52_week_low="+18.68%"
previous_close="15.33"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.40"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21725000"
short_ratio="19.63"
stock_exchange="NGM"
symbol="BOLD"
volume="62057"
weeks_range_52="13.06 - 20.74"
